Description: Endocrine cancers result from the abnormal cell growth of hormone-producing cells, like neuroendocrine tumors of the thyroid, adrenal, and pancreatic glands. Most endocrine cancers often have non-specific presentations or even remain asymptomatic and, therefore, are hard to diagnose in their initial stages. Molecular diagnostics and imaging have advanced the diagnosis and management of endocrine tumors. Targeted therapies and immunotherapy are rapidly becoming standard treatment modalities for specific endocrine cancers. Studies also emphasize genetic and environmental elements in the pathogenesis of these cancers. During DEWC, diabetes, and endocrinology experts will present the newest studies in treatment options for endocrine cancers with a view to innovative advancements in detection and therapy.